MLL |
Spindle organization |
Elongated spindles with dense or low microtubule formation/multipolar spindle formation. |
[130] |
Chromosomal alignment and segregation |
Delayed chromosomal alignment at metaphase plate. Formation of micronuclei. |
[111,130] |
Cytokinesis |
Formation of binucleated cells. |
[111,135] |
Cell proliferation |
Growth arrest at G1 Phase/defects in S-Phase progression. |
[111] |
Ubiquitination process (as E3 ligase) |
Delayed degradation and increased stability of MLL. |
[184] |
MLL2 |
Cell proliferation |
Defects in S-Phase progression. |
[111] |
Ubiquitination process, as E3 ligase |
Delayed degradation and increased stability of MLL2. |
[184] |
MLL3 |
Cell proliferation |
Defects in S-Phase progression. |
[111] |
Transcriptional coactivator, Pol II loading and eRNA synthesis at enhancers |
Reduces Pol II density in adjacent gene-bodies. |
[96] |
MLL4 |
Cell proliferation |
Defects in S-Phase progression |
[111] |
Transcriptional coactivator, Pol II loading and eRNA synthesis at enhancers |
Reduces Pol II density in adjacent gene-bodies. |
[96] |
SETD1A |
DNA damage response |
Supresses DDR genes and induces p53-dependent apoptosis/impaired DDR |
[120,123] |
Chromosomal alignment and segregation |
Delayed chromosomal alignment at metaphase plate. Formation of micronuclei. |
[111,130] |
Cytokinesis |
Formation of binucleated cells. |
[111] |
Non-histone protein methylation |
Reduced cellular proliferation in cancer cells. |
[168,173] |
Cell proliferation/viability |
Induced growth arrest |
[120] |
SETD1B |
Metabolic processes |
Reduction in HADHA, a mitochondrial trifunction protein and thus leads to accumulation of lipids. |
[32] |
Cell proliferation/ viability |
Altered cancer cell survival and growth. |
[32] |